| Literature DB >> 24232366 |
Carolina R Córdula1, Marcelo A Lima, Samuel K Shinjo, Tarsis F Gesteira, Laércio Pol-Fachin, Vivien J Coulson-Thomas, Hugo Verli, Edwin A Yates, Timothy R Rudd, Maria A S Pinhal, Leny Toma, Carl P Dietrich, Helena B Nader, Ivarne L S Tersariol.
Abstract
The structurally diverse polysaccharide lyase enzymes are distributed from plants to animals but share common catalytic mechanisms. One, heparinase I (F. heparinum), is employed in the production of the major anticoagulant drug, low molecular weight heparin, and is a mainstay of cell surface proteoglycan analysis. We demonstrate that heparinase I specificity and efficiency depend on the cationic form of the substrate. Ca(2+)-heparin, in which α-L-iduronate-2-O-sulfate residues adopt (1)C4 conformation preferentially, is a substrate, while Na(+)-heparin is an inhibitor. His and Tyr residues are identified in the catalytic step and a model based on molecular dynamics and docking is proposed, in which deprotonated His203 initiates β-elimination by abstracting the C5 proton of the α-L-iduonate-2-O-sulfate residue in the substrate, and protonated Tyr357 provides the donor to the hexosamine leaving group.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24232366 DOI: 10.1039/c3mb70370c
Source DB: PubMed Journal: Mol Biosyst ISSN: 1742-2051